Chain Drug Review - Schering-Plough gets okay to sell clarinex for allergies
Wednesday, January 7th, 2009 KENILWORTH, N.J. — Schering-Plough Corp. bas received Food and Drug Administration approval of Clarinex (desloratadine) for the treatment of seasonal allergic rhinitis (SAR).
The product builds upon the company’s heritage as a discoverer and developer of allergy and respiratory products as demonstrated by the success of its Claritin collection of nonsedating antihistamines and by Nasonex, a once-daily nasal st…
